Related references
Note: Only part of the references are listed.Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Nobumasa Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients
Stephanie J. Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma
Guoying Cao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS
Zheng Ma et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
J Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Share Paper
